Shattuck Labs Inc

-0.02 (-1.31%)
7:23:49 PM EDT: $1.75 +0.24 (+15.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)63.29M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.29 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$1.83
50-Day MA$2.27
200-Day MA$2.89
See more pivots

Shattuck Labs Inc Stock, NASDAQ:STTK

500 West 5th Street, Suite 1200, Austin, Texas 78701
United States of America
Phone: +1.512.900.4690
Number of Employees: 105


Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.